-

JOH丨Impact of HBV DNA Integration on Diagnosis, Treatment, and Prognosis of Chronic Hepatitis B
HBV infection is a global public health issue, with its chronic progression leading to severe liver diseases such as chronic hepatitis B (CHB), cirrhosis, and hepatocellular carcinoma (HCC). In recent years, the phenomenon of HBV DNA integrating into the host genome has garnered widespread attention as it unveils new mechanisms of HBV pathogenesis and significantly…
-

Pre-TIPS Assessment of Liver-Related Vascular Morphology Can Predict Overt Hepatic Encephalopathy
Portal hypertension can lead to complications such as variceal bleeding and ascites. Transjugular intrahepatic portosystemic shunt (TIPS) creates an artificial channel between the hepatic vein and portal vein to reduce portal pressure. TIPS is the only minimally invasive method that can reduce or even normalize portal pressure and is effective in controlling variceal bleeding and…
-

AIDS 2024丨Unique Changes in the Gut Virome of HIV-Exposed Uninfected Infants
At the 25th International AIDS Conference (AIDS 2024) in Munich, Germany, a study on the impact of HIV on the gut virome of children garnered significant attention. This research was conducted by scientists from the University of Washington in Seattle, Seattle Children’s Hospital, and the University of Cape Town in South Africa. The study revealed…
-

AIDS 2024丨Severe Depression in People with HIV Linked to Increased Neuroinflammation
Severe depression in people with HIV is a complex public health issue requiring urgent attention. The 25th International AIDS Conference (AIDS 2024) was held from July 22 to 26 in Munich, Germany, attracting 15,000 professionals and attendees from around the world to discuss the latest advancements and future challenges in AIDS prevention and treatment. At…
-

APACC2024 | Dr. Chunyan Li: Service Provision and Adherence Support for HIV Pre-Exposure Prophylaxis (PrEP)
Numerous studies have explored the use of long-acting antiretroviral therapy (Long-acting ART) for HIV pre-exposure prophylaxis (PrEP), achieving positive preventive outcomes. However, the promotion of long-acting PrEP still faces many challenges. Additionally, how can adherence to existing oral PrEP regimens be further improved? At the recently held 9th Asia Pacific AIDS & Co-infections Conference (APACC…
-

Dr. Fu Fu Zheng: New Advances in Prostate Cancer Research at the 2024 ASCO Meeting (Research Directions and Precision Therapy)
Prostate cancer is a common malignant tumor of the reproductive system, particularly affecting elderly men. Screening high-risk populations and tailoring treatment plans based on patient characteristics are crucial for improving cure rates and enhancing quality of life. Recently, the 2024 ASCO Annual Meeting unveiled numerous advancements in the precision treatment of prostate cancer. “Oncology Frontier”…
-

In-Depth Analysis丨Dr. Wei Li & Dr. Shaohua Zhang: First-Line Treatment Options for Patients with Recurrent Metastatic Triple-Negative Breast Cancer
For patients with recurrent metastatic triple-negative breast cancer (TNBC), would you choose “chemotherapy + immunotherapy” or “ADC” for treatment? At the 2024 Breast Cancer Summer Forum·Northern Salon “In-Depth Analysis” session, Dr. Wei Li from Jiangsu Provincial People’s Hospital and Dr. Shaohua Zhang from the Chinese PLA General Hospital presented their respective viewpoints. Dr. Wei Li…
-

In-Depth Analysis丨Dr. Wei Li & Dr. Shaohua Zhang: First-Line Treatment Options for Patients with Recurrent Metastatic Triple-Negative Breast Cancer
For patients with recurrent metastatic triple-negative breast cancer (TNBC), would you choose “chemotherapy + immunotherapy” or “ADC” for treatment? At the 2024 Breast Cancer Summer Forum·Northern Salon “In-Depth Analysis” session, Dr. Wei Li from Jiangsu Provincial People’s Hospital and Dr. Shaohua Zhang from the Chinese PLA General Hospital presented their respective viewpoints. Dr. Wei Li…